Balloon Introducer System Market - Growth Drivers and Challenges
Growth Drivers
- Growing Cases of Cardiovascular Diseases with Rising Cholesterol Issues – Many people with cholesterol do not exhibit any symptoms but increased levels of cholesterol will cause complications such as arrhythmia, stroke, and heart failure. The unhealthy eating habits of people owing to the adoption of fast foods, beverages, canned food products, and ready-made items with high calories are estimated to drive market growth. Also, the lack of physical activity and exercise among adults is estimated to boost the growth of the market. As per the reports about 95 million people in the U.S. aged 20 and above are suffering from cholesterol levels of more than 180 mg/dL and approximately 30 million adults are suffering from cholesterol levels of over 230 mg/dL as of 2022.
- Rising Government Initiatives to Improve Healthcare for People Suffering from Heart Disease – As per the data of Centers for Disease Control and Prevention (CDC), a national initiative was introduced in 2022 called ‘Million Hearts’ supported by CDC and the Centers for Medicare & Medicaid Services to avoid at least 1 million heart attacks and strokes within 5 years around the world.
- Rising Geriatric Population with Chronic Diseases Across the World – As per the records, over 90% of the elder population are living with at least one of the chronic conditions, and over about 80% are living with more than two chronic diseases in the U.S.
- Increase in Adoption of Unhealthy Eating Habits Among People – It is observed that in the U.S. about 670,000 people die of unhealthy eating habits annually owing to obesity and malnutrition diseases including cancer, heart disease, and diabetes.
Challenges
- Side Effects of Treatment Methods
- The complications of the balloon introducer system include bleeding at the catheter insertion place, blood clots, or damage to blood vessels surrounding the catheter, infection, the chance of stroke, loss of blood, abnormal heartbeats, and sometimes kidney failure. Hence the market is estimated to have a negative impact during the forecast period.
- Lack of Medical Reimbursement Policies for Treatment
- Insufficient Knowledge of the Procedures
Balloon Introducer System Market Size and Forecast:
|
Base Year |
2025 |
|
Forecast Year |
2026-2035 |
|
CAGR |
9.6% |
|
Base Year Market Size (2025) |
USD 4.19 billion |
|
Forecast Year Market Size (2035) |
USD 10.48 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of balloon introducer system is assessed at USD 4.55 billion.
The global balloon introducer system market size surpassed USD 4.19 billion in 2025 and is projected to witness a CAGR of over 9.6%, crossing USD 10.48 billion revenue by 2035.
North America is expected to command a majority revenue share of the balloon introducer system market by 2035, attributable to advanced healthcare infrastructure and substantial digital health investment.
Key players in the market include Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson, and Company (BD), Cardinal Health, Inc., Cardionovum GmbH, Koninklijke Philips N.V., Medtronic plc, MicroPort Scientific Corporation, OrbusNeich Medical Company Limited, Terumo Group.
